Browsing by Subject "Intraocular pressure"
Now showing 1 - 2 of 2
- Results Per Page
- Sort Options
Item Impact of Intraocular Pressure Maintenance on Sight Preservation(2002-05-01) Ratliff, Marla D.; Brown, Susan; Lykens, Kristine A.; Coggin, Claudia S.Ratliff, Marla D., Impact of Intraocular Pressure Maintenance on Sight Preservation. Master of Public Health (Health Services Research), May 2002, 35 pp., 3 tables, 1 figure, 40 titles. Purpose: The objective of the study was to review diurnal IOP control and its impact on sight preservation. Methods: This is a retrospective study used in patients with elevated IOP. Patient IOPs were measured every 4 hours over a 24-hour period. Qualified patients provided open label TRAVATAN to dose once a day for 2 weeks. Following 2 weeks of dosing, IOP measurements were taken every 4 hours for 36 hours. Additional IOP measurements were taken at 60 and 84 hours after the last dose of TRAVATAN. Results: The IOP changes from baseline were statistically significant (p≤0.0001) at all time points out to 36 hours. Even without additional dosing, substantial IOP reductions (6mm Hg) were maintained out to 84 hours. Conclusions: Use of TRAVATAN may have less impact on IOP maintenance due to non-compliance and missed doses. This could help prevent glaucomatous loss and preserve sight.Item INCREASED EXPRESSION OF ENDOTHELIN B RECEPTORS PRECEDES RETINAL GANGLION CELL DEATH IN A RODENT MODEL OF GLAUCOMA(2013-04-12) Minton, Alena Z.Purpose: Endothelin B (ETB) receptors have been shown to be involved in the pathogenesis of glaucoma. However, the precise sequence of molecular events involving ETB receptor expression and retinal ganglion cell death is not completely understood. This study was aimed at investigating whether the expression of ETB receptors precedes retinal ganglion cell loss in vivo in the Morrison's elevated intraocular pressure (IOP) model of glaucoma in rats. Methods: Intraocular pressure (IOP) was elevated in one eye of retired breeders Brown Norway rats using the Morrison's method (injection of hypertonic saline through episcleral veins), while the contralateral eye served as control. Retinas were collected after 1 and 2 weeks of IOP elevation, sectioned and stained for ETB receptor expression by immunohistochemistry. In a separate set of experiments, retired breeders Brown Norway rats were used for retrograde labeling of retinal ganglion cells (RGCs) with Fluoro-gold. Following retrograde labeling, IOP was elevated in one eye using the Morrison's method, while the contralateral eye served as control. After IOP was elevated, rats were maintained for 2 weeks and sacrificed. Fluoro-gold labeled retinas were isolated, flat-mounted, and images taken using a Zeiss LSM-510 confocal microscope. Fluoro-gold-labeled RGCs were counted in three eccentricities from the optic nerve head. In addition, optic nerves were isolated from Brown Norway rats following 2 weeks of IOP elevation, sectioned and stained using p-phenylenediamine. Confocal images were taken and morphology of optic nerve axons was compared. Results: Immunohistochemical analysis of retinal sections showed no appreciable change in ETB receptor immunostaining following 1 week of IOP elevation. However, IOP elevation for 2 weeks produced increased expression of ETB receptor in the RGCs, inner plexiform layer (IPL) and inner nuclear layer (INL). In addition, IOP elevation for 2 weeks resulted in 25% loss of RGCs in the first eccentricity, while no significant loss was seen in the second and third eccentricities. Moreover, there was no appreciable damage observed in the optic nerve axons after 2 weeks of IOP elevation. Conclusions: Early increase in expression of ETB receptors (at 2 weeks of IOP elevation) could contribute to RGC loss and damage to the optic nerve axons.